{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:23:37Z","timestamp":1792632217096,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T00:00:00Z","timestamp":1679702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Mammography (MG) is the standard imaging in surveillance of women with a personal history of breast cancer or DCIS (PHBC), supplemented with ultrasound. Contrast Enhanced Mammography (CEM) has higher sensitivity than MG and US. We report the performance of CEM compared with MG\u2009\u00b1\u2009US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study of patients undergoing their first surveillance CEM in an Australian hospital setting between June 2006 and October 2020. Cases where a patient was recalled for assessment were identified, recording radiology, pathology and treatment details. Blinded re-reading of recalled cases was performed to determine the contribution of contrast. Use of surveillance US across the board was assessed for the period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>73\/1191 (6.1%) patients were recalled. 35 (48%) were true positives (TP), with 26 invasive cancers and 9 cases of DCIS, while 38 (52%) were false positive (FP) with a positive predictive value (PPV) 47.9%. 32\/73 were recalled due to MG findings, while 41\/73 were only recalled due to Contrast. 14\/73 had \u2018minimal signs\u2019 with a lesion identifiable on MG with knowledge of the contrast finding, while 27\/73 were visible only with contrast. 41% (17\/41) recalled due to contrast were TP. Contrast-only TPs were found with low and high mammographic density (MD). Screening breast US reduced by 55% in the year after CEM was implemented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared to MG, CEM as a single surveillance modality for those with PHBC has higher sensitivity and comparable specificity, identifying additional malignant lesions that are clinically significant. Investigation of interval cancer and subsequent round outcomes is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-023-06916-0","type":"journal-article","created":{"date-parts":[[2023,3,25]],"date-time":"2023-03-25T15:02:48Z","timestamp":1679756568000},"page":"221-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Contrast enhanced mammography in breast cancer surveillance"],"prefix":"10.1007","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-1717","authenticated-orcid":false,"given":"Kenneth","family":"Elder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Nickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Box","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clair","family":"Shadbolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Bruce","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,25]]},"reference":[{"key":"6916_CR1","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1001\/jama.2011.188","volume":"305","author":"N Houssami","year":"2011","unstructured":"Houssami N, Abraham LA, Miglioretti DL, Sickles EA, Kerlikowske K, Buist DSM et al (2011) Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer. JAMA 305:790\u2013799. https:\/\/doi.org\/10.1001\/jama.2011.188","journal-title":"JAMA"},{"key":"6916_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2214\/ajr.16.16300","volume":"208","author":"DL Lam","year":"2017","unstructured":"Lam DL, Houssami N, Lee JM (2017) Imaging surveillance after primary breast cancer treatment. Am J Roentgenol 208:676\u2013686. https:\/\/doi.org\/10.2214\/ajr.16.16300","journal-title":"Am J Roentgenol"},{"key":"6916_CR3","doi-asserted-by":"crossref","unstructured":"Consortium F the BCS, Buist DSM, Abraham LA, Barlow WE, Krishnaraj A, Holdridge RC, et al. Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer. Breast Cancer Res Tr 2010; 124:863\u2013873..","DOI":"10.1007\/s10549-010-1106-6"},{"key":"6916_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/s1470-2045(16)30101-2","volume":"17","author":"D Bernardi","year":"2016","unstructured":"Bernardi D, Macaskill P, Pellegrini M, Valentini M, Fant\u00f2 C, Ostillio L et al (2016) Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol 17:1105\u20131113. https:\/\/doi.org\/10.1016\/s1470-2045(16)30101-2","journal-title":"Lancet Oncol"},{"key":"6916_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s1470-2045(13)70134-7","volume":"14","author":"S Ciatto","year":"2013","unstructured":"Ciatto S, Houssami N, Bernardi D, Caumo F, Pellegrini M, Brunelli S et al (2013) Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol 14:583\u2013589. https:\/\/doi.org\/10.1016\/s1470-2045(13)70134-7","journal-title":"Lancet Oncol"},{"key":"6916_CR6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018172119","author":"P Pattacini","year":"2018","unstructured":"Pattacini P, Nitrosi A, Rossi PG, Iotti V, Ginocchi V, Ravaioli S et al (2018) Digital mammography versus digital mammography plus tomosynthesis for breast cancer screening: the reggio emilia tomosynthesis randomized trial. Radiology. https:\/\/doi.org\/10.1148\/radiol.2018172119","journal-title":"Radiology"},{"key":"6916_CR7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","volume":"299","author":"WA Berg","year":"2008","unstructured":"Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, B\u00f6hm-V\u00e9lez M et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299:2151\u20132163. https:\/\/doi.org\/10.1001\/jama.299.18.2151","journal-title":"JAMA"},{"key":"6916_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41416-020-0928-1","volume":"123","author":"W-H Yuan","year":"2020","unstructured":"Yuan W-H, Hsu H-C, Chen Y-Y, Wu C-H (2020) Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis. Brit J Cancer 123:673\u2013688. https:\/\/doi.org\/10.1038\/s41416-020-0928-1","journal-title":"Brit J Cancer"},{"key":"6916_CR9","doi-asserted-by":"publisher","unstructured":"Harada-Shoji N, Suzuki A, Ishida T, Zheng Y-F, Narikawa-Shiono Y, Sato-Tadano A, et al. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40\u201349 Years With Varying Breast Density Undergoing Screening Mammography. Jama Netw Open 2021;4:e2121505. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.21505.","DOI":"10.1001\/jamanetworkopen.2021.21505"},{"key":"6916_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0140-6736(15)00774-6","volume":"387","author":"N Ohuchi","year":"2016","unstructured":"Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng Y-F et al (2016) Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet 387:341\u2013348. https:\/\/doi.org\/10.1016\/s0140-6736(15)00774-6","journal-title":"Lancet"},{"key":"6916_CR11","doi-asserted-by":"publisher","unstructured":"Kim S-Y, Cho N, Kim SY, Choi Y, Kim ES, Ha SM, et al. Supplemental Breast US Screening in Women with a Personal History of Breast Cancer: A Matched Cohort Study. Radiology 2020;295:191691. https:\/\/doi.org\/10.1148\/radiol.2020191691.","DOI":"10.1148\/radiol.2020191691"},{"key":"6916_CR12","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2012.388","volume":"307","author":"WA Berg","year":"2012","unstructured":"Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG et al (2012) Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk. JAMA 307:1394\u20131404. https:\/\/doi.org\/10.1001\/jama.2012.388","journal-title":"JAMA"},{"key":"6916_CR13","doi-asserted-by":"publisher","unstructured":"Berg WA, Bandos AI, Mendelson EB, Lehrer D, Jong RA, Pisano ED. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666. Jnci J National Cancer Inst 2016;108:djv367. https:\/\/doi.org\/10.1093\/jnci\/djv367.","DOI":"10.1093\/jnci\/djv367"},{"key":"6916_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.breast.2020.11.007","volume":"54","author":"L Bromley","year":"2020","unstructured":"Bromley L, Xu J, Loh S-W, Chew G, Lau E, Yeo B (2020) Breast ultrasound in breast cancer surveillance; incremental cancers found at what cost? Breast Official J European Soc Mastology 54:272\u2013277. https:\/\/doi.org\/10.1016\/j.breast.2020.11.007","journal-title":"Breast Official J European Soc Mastology"},{"key":"6916_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1148\/radiol.2021203074","volume":"300","author":"GR Kim","year":"2021","unstructured":"Kim GR, Cho N, Kim S-Y, Han W, Moon WK (2021) Interval Cancers after Negative Supplemental Screening Breast MRI Results in Women with a Personal History of Breast Cancer. Radiology 300:314\u2013323. https:\/\/doi.org\/10.1148\/radiol.2021203074","journal-title":"Radiology"},{"key":"6916_CR16","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/nejmoa1903986","volume":"381","author":"MF Bakker","year":"2019","unstructured":"Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM et al (2019) Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. New Engl J Med 381:2091\u20132102. https:\/\/doi.org\/10.1056\/nejmoa1903986","journal-title":"New Engl J Med"},{"key":"6916_CR17","doi-asserted-by":"publisher","unstructured":"Houben IPL, Voorde PV de, Jeukens CRLPN, Wildberger JE, Kooreman LF, Smidt ML, et al. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits. Eur J Radiol 2017;94:31\u20137. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.004.","DOI":"10.1016\/j.ejrad.2017.07.004"},{"key":"6916_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.crad.2018.05.005","volume":"73","author":"JJ James","year":"2018","unstructured":"James JJ, Tennant SL (2018) Contrast-enhanced spectral mammography (CESM). Clin Radiol 73:715\u2013723. https:\/\/doi.org\/10.1016\/j.crad.2018.05.005","journal-title":"Clin Radiol"},{"key":"6916_CR19","doi-asserted-by":"publisher","unstructured":"Fallenberg EM, Schmitzberger FF, Amer H, Ingold-Heppner B, Balleyguier C, Diekmann F, et al. Contrast-enhanced spectral mammography vs. mammography and MRI\u2014clinical performance in a multi-reader evaluation. Eur Radiol 2017;27:2752\u201364. https:\/\/doi.org\/10.1007\/s00330-016-4650-6.","DOI":"10.1007\/s00330-016-4650-6"},{"key":"6916_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4048\/jbc.2018.21.e62","volume":"21","author":"EY Kim","year":"2018","unstructured":"Kim EY, Youn I, Lee KH, Yun J-S, Park YL, Park CH et al (2018) Diagnostic value of contrast-enhanced digital mammography versus contrast-enhanced magnetic resonance imaging for the preoperative evaluation of breast cancer. J Breast Cancer 21:453\u2013462. https:\/\/doi.org\/10.4048\/jbc.2018.21.e62","journal-title":"J Breast Cancer"},{"key":"6916_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/rct.0000000000000832","volume":"43","author":"D Xing","year":"2019","unstructured":"Xing D, Lv Y, Sun B, Xie H, Dong J, Hao C et al (2019) Diagnostic value of contrast-enhanced spectral mammography in comparison to magnetic resonance imaging in breast lesions. J Comput Assist Tomo 43:245\u2013251. https:\/\/doi.org\/10.1097\/rct.0000000000000832","journal-title":"J Comput Assist Tomo"},{"key":"6916_CR22","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3390\/cancers12123495","volume":"12","author":"J Gluskin","year":"2020","unstructured":"Gluskin J, Saccarelli CR, Avendano D, Marino MA, Bitencourt AGV, Pilewskie M et al (2020) Contrast-enhanced mammography for screening women after breast conserving surgery. Cancers 12:3495. https:\/\/doi.org\/10.3390\/cancers12123495","journal-title":"Cancers"},{"issue":"1","key":"6916_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1148\/radiol.2019182660","volume":"293","author":"JS Sung","year":"2019","unstructured":"Sung JS, Lebron L, Keating D, D\u2019Alessio D, Comstock CE, Lee CH, Pike MC, Ayhan M, Moskowitz CS, Morris EA, Jochelson MS (2019) Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer. Radiology 293(1):81\u201388. https:\/\/doi.org\/10.1148\/radiol.2019182660","journal-title":"Radiology"},{"issue":"5","key":"6916_CR24","doi-asserted-by":"publisher","first-page":"W267","DOI":"10.2214\/AJR.17.19355","volume":"211","author":"V Sorin","year":"2018","unstructured":"Sorin V, Yagil Y, Yosepovich A, Shalmon A, Gotlieb M, Neiman OH, Sklair-Levy M (2018) Contrast-enhanced spectral mammography in women with intermediate breast cancer risk and dense breasts. AJR Am J Roentgenol 211(5):W267\u2013W274. https:\/\/doi.org\/10.2214\/AJR.17.19355","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"6916_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.crad.2019.06.002","volume":"74","author":"MH Helal","year":"2019","unstructured":"Helal MH, Mansour SM, Ahmed HA, Abdel Ghany AF, Kamel OF, Elkholy NG (2019) The role of contrast-enhanced spectral mammography in the evaluation of the postoperative breast cancer. Clin Radiol 74(10):771\u2013781. https:\/\/doi.org\/10.1016\/j.crad.2019.06.002","journal-title":"Clin Radiol"},{"key":"6916_CR26","volume-title":"Release 15","author":"Stata Statistical Software","year":"2017","unstructured":"Stata Statistical Software (2017) Release 15. StataCorp LLC, College Station, TX"},{"key":"6916_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-008-0023-4","volume":"114","author":"WL Lu","year":"2008","unstructured":"Lu WL, Jansen L, Post WJ, Bonnema J, de Velde JCV, Bock GHD (2008) Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Tr 114:403. https:\/\/doi.org\/10.1007\/s10549-008-0023-4","journal-title":"Breast Cancer Res Tr"},{"key":"6916_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3390\/jcm8112021","volume":"8","author":"E Lynge","year":"2019","unstructured":"Lynge E, Vejborg I, Andersen Z, von Euler-Chelpin M, Napolitano G (2019) Mammographic density and screening sensitivity, breast cancer incidence and associated risk factors in Danish breast cancer screening. J Clin Medicine 8:2021. https:\/\/doi.org\/10.3390\/jcm8112021","journal-title":"J Clin Medicine"},{"key":"6916_CR29","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1002\/cncr.24638","volume":"115","author":"T Cil","year":"2009","unstructured":"Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA et al (2009) Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 115:5780\u20135787. https:\/\/doi.org\/10.1002\/cncr.24638","journal-title":"Cancer"},{"key":"6916_CR30","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/jamainternmed.2018.8372","volume":"179","author":"JM Lee","year":"2019","unstructured":"Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA et al (2019) Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. Jama Intern Med 179:658\u2013667. https:\/\/doi.org\/10.1001\/jamainternmed.2018.8372","journal-title":"Jama Intern Med"},{"key":"6916_CR31","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/s0140-6736(11)61350-0","volume":"378","author":"M Morrow","year":"2011","unstructured":"Morrow M, Waters J, Morris E (2011) MRI for breast cancer screening, diagnosis, and treatment. Lancet 378:1804\u20131811. https:\/\/doi.org\/10.1016\/s0140-6736(11)61350-0","journal-title":"Lancet"},{"key":"6916_CR32","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016161444","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S (2017) Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology. https:\/\/doi.org\/10.1148\/radiol.2016161444","journal-title":"Radiology"},{"key":"6916_CR33","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/1759-7714.13400","volume":"11","author":"W Xiang","year":"2020","unstructured":"Xiang W, Rao H, Zhou L (2020) A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer. Thorac Cancer 11:1423\u20131432. https:\/\/doi.org\/10.1111\/1759-7714.13400","journal-title":"Thorac Cancer"},{"key":"6916_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0140-6736(07)61232-x","volume":"370","author":"CK Kuhl","year":"2007","unstructured":"Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485\u2013492. https:\/\/doi.org\/10.1016\/s0140-6736(07)61232-x","journal-title":"Lancet"},{"key":"6916_CR35","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1148\/radiol.2021204581","volume":"300","author":"JM Lee","year":"2021","unstructured":"Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K et al (2021) Digital mammography and breast tomosynthesis performance in women with a personal history of breast cancer, 2007\u20132016. Radiology 300:290\u2013300. https:\/\/doi.org\/10.1148\/radiol.2021204581","journal-title":"Radiology"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-023-06916-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-023-06916-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:51:16Z","timestamp":1683813076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-023-06916-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6916"],"URL":"https:\/\/doi.org\/10.1007\/s10549-023-06916-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2214507\/v1","asserted-by":"object"}]},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,25]]},"assertion":[{"value":"9 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This project was approved as a Quality Assurance project by the Melbourne Health Research and Ethics Committee, QA2019129.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}